- Rank in Search Criteria: 2981
World Rank (Aug-2026): 9,315
Market Cap (Aug-2026): 0.986 Billion USD
World Rank (Jan-05-2024): 12,817
Market Cap (Jan-05-2024): 0.48 Billion USD
World Rank (Jul-30-2023): 11423
Market Cap (Jul-30-2023): 0.62 Billion USD
World Rank (Jan-2022): 10,875
Market Cap (Jan-2022): 0.77 Billion USDHeadquarters Country: USA Annual Revenue in USD: 10 Million USD
Annual Operating Income in USD: -158 Million USD
Annual Net Income in USD: -114 Million USD
Annual Results for Period ending: For year ending December-2025
- Rank in Search Criteria: 2982
World Rank (Aug-2026): 9,316
Market Cap (Aug-2026): 0.986 Billion USD
World Rank (Jan-05-2024): 14,008
Market Cap (Jan-05-2024): 0.40 Billion USD
World Rank (Jul-30-2023): 15478
Market Cap (Jul-30-2023): 0.32 Billion USD
World Rank (Jan-2022): 18,193
Market Cap (Jan-2022): 0.23 Billion USDHeadquarters Country: USA Annual Revenue in USD: 839 Million USD
Annual Operating Income in USD: 61 Million USD
Annual Net Income in USD: 45 Million USD
Annual Results for Period ending: For year ending May-2026
- Rank in Search Criteria: 2983
World Rank (Aug-2026): 9,316
World Rank (Jan-05-2024): 9,316
World Rank (Jul-30-2023): 9316
Market Cap (Jul-30-2023): 0.90 Billion USD
- Rank in Search Criteria: 2984
World Rank (Aug-2026): 9,317
Market Cap (Aug-2026): 0.986 Billion USD
World Rank (Jan-05-2024): 20,729
Market Cap (Jan-05-2024): 0.12 Billion USD
World Rank (Jul-30-2023): 22447
Market Cap (Jul-30-2023): 0.09 Billion USD
World Rank (Jan-2022): 19,806
Market Cap (Jan-2022): 0.17 Billion USDHeadquarters Country: USA Annual Operating Income in USD: -179 Million USD
Annual Net Income in USD: -174 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: Solid Biosciences is a Life Science company focused on developing transformative treatments to improve the lives of patients living with Duchenne muscular dystrophy (Duchenne). The company estimated annual revenue is currently 12.4 million USD per year. The headquarters is in USA.
- Rank in Search Criteria: 2985
World Rank (Aug-2026): 9,322
Market Cap (Aug-2026): 0.984 Billion USD
World Rank (Jan-05-2024): 8,915
Market Cap (Jan-05-2024): 0.94 Billion USD
World Rank (Jul-30-2023): 8594
Market Cap (Jul-30-2023): 1.03 Billion USD
World Rank (Jan-2022): 7,639
Market Cap (Jan-2022): 1.43 Billion USDHeadquarters Country: USA Annual Net Income in USD: 69 Million USD
Annual Results for Period ending: For year ending December-2025Company Profile: Southside Bancshares is a Bank Holding company. It is having approximately $7.19B in assets, operate 57 branches in East, North, Central and Southeast Texas. The company also operates a network of 80 local ATMs and is affiliated with more than 55,000 foreign ATMs worldwide. The headquarters is in USA.
- Rank in Search Criteria: 2986
World Rank (Aug-2026): 9,323
Market Cap (Aug-2026): 0.984 Billion USD
World Rank (Jan-05-2024): 10,947
Market Cap (Jan-05-2024): 0.66 Billion USD
World Rank (Jul-30-2023): 8389
Market Cap (Jul-30-2023): 1.08 Billion USD
Headquarters Country: USA Annual Revenue in USD: 258 Million USD
Annual Operating Income in USD: -72 Million USD
Annual Net Income in USD: -54 Million USD
Annual Results for Period ending: For year ending December-2025Employee Count: 704
Employee Count as of Date: As on 2022
Company Profile: NEXTDOOR is social media company with headquarters is in USA. It is a private environment designed just for you and your neighbours.
- Rank in Search Criteria: 2987
World Rank (Aug-2026): 9,327
Market Cap (Aug-2026): 0.983 Billion USD
World Rank (Jan-05-2024): 7,261
Market Cap (Jan-05-2024): 1.34 Billion USD
World Rank (Jul-30-2023): 8968
Market Cap (Jul-30-2023): 0.95 Billion USD
World Rank (Jan-2022): 13,740
Market Cap (Jan-2022): 0.48 Billion USDAnnual Revenue in USD: 682 Million USD
Annual Net Income in USD: 20 Million USD
Annual Results for Period ending: Dec-2020 ending yearCompany Profile: MARCOPOLO manufacture bus bodies. Headquarters is in Brazil.
- Rank in Search Criteria: 2988
World Rank (Aug-2026): 9,330
Market Cap (Aug-2026): 0.983 Billion USD
World Rank (Jan-05-2024): 8,741
Market Cap (Jan-05-2024): 0.97 Billion USD
World Rank (Jul-30-2023): 7438
Market Cap (Jul-30-2023): 1.31 Billion USD
World Rank (Jan-2022): 5,689
Market Cap (Jan-2022): 2.33 Billion USDAnnual Revenue in USD: 288 Million USD
Annual Net Income in USD: 334 Million USD
Annual Results for Period ending: Dec-2021 ending yearCompany Profile: NorthWest Healthcare Properties Real Estate Investment Trust is a Healthcare Real Estate Investment Trust company. It is diversified portfolio of 189 income producing properties and 15.3 million square feet of gross leasable area located throughout major markets and the REIT leverages over 200 professionals across 9 offices in 5 countries to serve as a long term real estate partner to healthcare operators. The headquarters is in Canada.
- Rank in Search Criteria: 2989
World Rank (Aug-2026): 9,334
Market Cap (Aug-2026): 0.982 Billion USD
World Rank (Jan-05-2024): 12,620
World Rank (Jul-30-2023): 12620
Market Cap (Jul-30-2023): 0.51 Billion USD
World Rank (Jan-2022): 17,081
Market Cap (Jan-2022): 0.28 Billion USDHeadquarters Country: USA Annual Revenue in USD: 127 Million USD
Annual Operating Income in USD: 6 Million USD
Annual Net Income in USD: 5 Million USD
Annual Results for Period ending: For year ending December-2013
- Rank in Search Criteria: 2990
World Rank (Aug-2026): 9,336
Market Cap (Aug-2026): 0.981 Billion USD
World Rank (Jan-05-2024): 2,991
Market Cap (Jan-05-2024): 4.86 Billion USD
World Rank (Jul-30-2023): 2609
Market Cap (Jul-30-2023): 5.81 Billion USD
World Rank (Jan-2022): 3,198
Market Cap (Jan-2022): 5.17 Billion USDHeadquarters Country: USA Annual Revenue in USD: 2,730 Million USD
Annual Operating Income in USD: -919 Million USD
Annual Net Income in USD: -1,132 Million USD
Annual Results for Period ending: For year ending December-2025Employee Count: 7,000
Employee Count as of Date: As on 2022
Company Profile: Quidel Corporation is a Diagnostic Healthcare Manufacturer Serving company. It core competencies and capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development and molecular assay development. The company is delivering a continuum of diagnostic solutions from advanced lateral flow and direct fluorescent antibody to molecular diagnostic tests that further improve the quality of healthcare. The headquarters is in USA.